Eukaryotic and prokaryotic cells synthesize purine nucleotides either de novo from small precursors or through salvage pathways from preformed purine. Exogenous and endogenous ribonucleosides are utilized through two salvage pathways. One pathway involves purine nucleoside phosphorylase, which catalyzes the phosphorolysis of ribonucleosides to the corresponding nucleobase and ribose 1-phosphate. The nucleobase is subsequently phosphoribosylated to its corresponding nucleoside monophosphate by purine phosphoribosyltransferase. The other pathway involves ribonucleoside kinase, which catalyzes the direct phosphorylation of the ribonucleoside to the corresponding ribonucleoside 5Ј-monophosphate.
Guanosine kinase (ATP:guanosine 5Ј-phosphotransferase) catalyzes the phosphorylation of guanosine to its monophosphate form. Although guanosine kinase activity has been reported both in eukaryotic and prokaryotic cells, in most organisms the existence of guanosine kinase activity is obscure due to difficulties in detecting the weak activity in crude enzyme systems (3) . Only the Escherichia coli gsk gene, which encodes guanosine kinase, has been genetically identified (12, 14) and cloned (10, 21) . On the other hand, the existence of guanosine kinase activity in Bacillus subtilis has been neglected for the physiological analyses of mutants (9, 27) .
Brevibacterium acetylicum is a coryneform, gram-positive bacterium (15) . B. acetylicum has been known to possess purine nucleoside phosphorylase activity, and the purine nucleoside phosphorylase of B. acetylicum ATCC 954 has been purified and characterized (30) . We have found that B. acetylicum ATCC 953 has direct guanosine phosphorylating activity as well as guanosine phosphorylase activity. We previously purified the guanosine kinase of B. acetylicum ATCC 953 to homogeneity and characterized in detail its enzymatic properties (34) . The guanosine kinase phosphorylates inosine and 2Ј-deoxyguanosine as well as guanosine; however, the kinetic parameters indicate that guanosine is by far the most efficient phosphate acceptor for the enzyme. In addition to ATP and dATP, GTP and dGTP have been shown to be effective phosphate donors. The addition of CMP and CTP nucleotides stimulates guanosine kinase activity. These analyses suggest that guanosine kinase activity might be regulated by the in vivo nucleotide concentrations. In this report we describe the molecular cloning of the gsk gene, which encodes the guanosine kinase of B. acetylicum ATCC 953, and the transcriptional analysis of the gsk gene.
MATERIALS AND METHODS
Strains, plasmids, and media. The B. acetylicum strain ATCC 953, a wild-type strain, was used in this study (15) . B. acetylicum was grown in CM2G medium (19) . E. coli JM109 (38) was used for the cloning and sequencing procedure. Luria-Bertani medium (25) was used as a complex medium for E. coli. E. coli was grown aerobically at 37°C, and B. acetylicum was grown at 30°C. The plasmids pSTV28 (Takara Shuzo, Kyoto, Japan), derived from pACYC184 (7), and pMW218 (Wako, Osaka, Japan), derived from pSC101 (4), were used for cloning of genomic fragments, and pUC18 (36) and its derivatives pHSG298 and pHSG398 (33) were used for cloning the subfragments that were used as sequencing templates.
Analysis of N-terminal amino acid sequence. Approximately 2 g of the purified guanosine kinase (34) was concentrated in a Centricon-10 concentrator (Amicon, Beverly, Mass.) and blotted onto a polyvinylidene fluoride membrane by using a ProSpin device (Perkin-Elmer, Foster City, Calif.). The N-terminal amino acid sequence was analyzed by automated Edman degradation employing a gas-phase protein sequencer (model 477A protein sequencer; Perkin-Elmer).
DNA manipulations. All restriction enzymes, T4 DNA ligase, T4 polynucleotide kinase, Klenow polymerase, and calf intestine alkaline phosphatase were obtained from Takara Shuzo. The chromosomal DNA of B. acetylicum was isolated essentially as described by Saito and Miura (24) . Plasmid DNA was extracted from E. coli by the alkaline extraction procedure (5) . Sequencing was performed by the dideoxy chain termination method (26) using a Taq Dye Deoxy Terminator Cycle Sequencing kit (Perkin-Elmer) and a model 373S DNA sequencer (Perkin-Elmer). Synthetic universal and gsk-specific oligonucleotides were used as primers. Sequence data were compiled and analyzed by using Genetyx-Mac genetic information processing software (Software Development, Tokyo, Japan). The BLAST program (DNA Data Bank of Japan) was used for finding ungapped local alignments (2) .
DNA hybridization. An 83-bp fragment corresponding to the N-terminal amino acid sequence of the B. acetylicum gsk gene was amplified from B. acetylicum chromosomal DNA by PCR using AmpliTaq DNA polymerase (PerkinElmer). The amplified fragment was purified from an agarose gel, labeled with [␥-32 P]ATP (Amersham, Little Chalfont, Buckinghamshire, United Kingdom) and T4 polynucleotide kinase, and used as a probe for Southern hybridization (31) . Restricted chromosomal DNA from B. acetylicum was separated in a 0.8% agarose gel and transferred onto a GeneScreen Plus filter (Dupont, Boston, Mass.). E. coli colonies for colony hybridization were transferred onto a Hybond-N filter (Amersham). Blotting, hybridization, and washing procedures were performed as described elsewhere (25) .
Enzyme assays. B. acetylicum or recombinant E. coli cells were cultured in 50 ml of medium, harvested, washed twice with 0.9% NaCl, resuspended in 2 ml of buffer A (50 mM Tris-HCl [pH 7.5], 100 mM KCl, 1 mM dithiothreitol), and disrupted by sonication. After centrifugation at 18,000 ϫ g for 30 min, the supernatant was applied to a Sephadex G-25 column (Pharmacia, Uppsala, Sweden). The desalted fractions were diluted with buffer A, and 5 l was added to a 45-l reaction mixture as a crude enzyme solution. The components of the reaction mixture and the procedure for measuring guanosine kinase were described in a previous report (34) . For the guanosine phosphorylase assay, a reaction mixture containing 100 mM potassium phosphate buffer (pH 7.5), 100 mM KCl, 0.04 mM [8- 14 C]guanosine (56 mCi/mmol; Moravek Biochemicals, Brea, Calif.), 0.16 mM guanosine, and enzyme solution in a total volume of 50 l was incubated at 30°C for 10 min. Two microliters of the reaction mixture was spotted onto silica gel plates (Merck, Whitehouse Station, N.J.), developed in isopropanol-aqueous ammonia-water (7:2:1, vol/vol/vol), and air dried. The activity of guanosine phosphorylase was determined by measuring the conversion of [8- 14 C]guanosine to [8] [9] [10] [11] [12] [13] [14] C]guanine. The protein concentration was determined with a protein assay kit (Bio-Rad, Hercules, Calif.) with bovine serum albumin as the standard.
RNA isolation and Northern hybridization. B. acetylicum ATCC 953 was grown in 100 ml of medium and harvested in early exponential growth phase (optical density at 600 nm [OD 600 ] ϭ 1.0) by centrifugation at 10,000 ϫ g for 5 min. Total RNA was isolated by the acid guanidinium thiocyanate-phenol-chloroform method (8) . The Northern hybridization procedure has been described previously (35) . The 0.7-kb SalI fragment was isolated from the plasmid pKE1.4, labeled with [␣-
32 P]dCTP (Amersham) and a Klenow fragment, and used as a probe for Northern hybridization. A 0.24-to-9.5-kb RNA ladder (Gibco-BRL, Rockville, Md.) was used for size determinations.
Primer extension. For examination of growth phase-dependent expression, total RNA was extracted from early (OD 600 ϭ 1.7)-, middle (OD 600 ϭ 3.8)-, and late (OD 600 ϭ 5.4)-logarithmic-phase cells. A primer (5Ј-GTCGACGAATACT TTTCC-3Ј) complementary to the sequence from positions 581 to 564 of the KpnI-BamHI fragment (Fig. 1 ) was synthesized and labeled with T4 polynucleotide kinase by using [␥- 32 P]ATP (Amersham). Ten micrograms of total RNA and 2 pmol of the labeled primer were hybridized in 30 l of 40 mM piperazine-N,NЈ-bis(2-ethanesulfonic acid) (pH 6.4) in a solution containing 1 mM EDTA, 0.4 M NaCl, and 80% (vol/vol) formamide at 55°C for 14 h. The mixture was ethanol precipitated, washed with 70% ethanol, and air dried. The pellet was dissolved in 20 l of 10 mM Tris-HCl, pH 8.8, in a solution containing 50 mM KCl, 0.1% Triton X-100 (vol/vol), 5 mM MgCl 2 , 1 mM deoxynucleoside triphosphates, and 20 U of RNasin (Promega, Madison, Wis.). Then, 10 U of avian myeloblastosis virus reverse transcriptase (Promega) was added and incubated at 42°C for 2 h. The reaction was stopped by adding 1 l of 0.5 M EDTA (pH 8.0), and the RNA was removed by incubation with 5 ng of RNase A at 37°C for 30 min. After phenol-chloroform extraction and ethanol precipitation, the reaction product was dissolved in 4 l of 10 mM Tris-HCl (pH 7.5) in a solution containing 1 mM EDTA plus 6 l of formamide loading buffer, and 3 l of this mixture was loaded onto a 6% (wt/vol) polyacrylamide sequencing gel as described previously (25) .
Nucleotide sequence accession number. The B. acetylicum gsk sequence reported in this paper has been submitted to the DDBJ, EMBL, and GenBank databases and has been assigned accession no. AB005149.
RESULTS AND DISCUSSION
Isolation of the B. acetylicum gsk gene. The N-terminal amino acid sequence of the purified B. acetylicum guanosine kinase was analyzed. The determined sequence of 28 amino acids (aa) was NH 2 -Met-Asn-Lys-Ile-Ala-Val-Ile-Gly-Lys-ValPhe-Val-Asp-Ile-Lys-Gly-Thr-Xaa-Phe-Ala-Pro-Leu-His-LysAsp-Ala-Lys-Asn (the 18th residue could not be identified). Primers oriented inside and positioned on both sides of the determined sequence were designed and synthesized by mixing at the third positions of codons. An 83-bp fragment corresponding to the N-terminal region was amplified from B. acetylicum genomic DNA by PCR. The nucleotide sequence of the 83-bp fragment matched the N-terminal amino acid sequence completely, and the 18th residue was identified as serine. Southern blot analysis of restriction digests of B. acetylicum genomic DNA, using this fragment as a probe, revealed a 3.6-kb EcoRI fragment and a 5.9-kb BamHI fragment; however, we failed to obtain either of these fragments from the genome directly by colony hybridization. Thus, the cassette ligation-mediated PCR method (13) was employed. A 1.2-kb fragment from the N-terminal region to the downstream EcoRI site and a 2.2-kb fragment from the N-terminal region to the upstream EcoRI site were amplified. The 1.2-kb downstream fragment was cloned into pUC18, but the 2.2-kb upstream fragment could not be cloned even into a low-copynumber vector. A 0.6-kb KpnI restriction fragment from the N-terminal region to the upstream KpnI site was cloned. The reason why we could not obtain the 3.6-kb EcoRI fragment and 5.9-kb BamHI fragment from the genome directly may have been that there was an upstream gene which inhibited the growth of E. coli. Subsequently, 1.8-kb size-selected fragments were recovered from EcoRI and KpnI restriction digests of genomic DNA, ligated to pSTV28, and transformed into E. coli JM109. The transformants were screened by colony hybridization, with the 1.2-kb fragment from the N-terminal region to the downstream EcoRI site used as a probe. As a result, a plasmid clone which contained the 1.8-kb KpnI-EcoRI fragment was selected and designated pKE1.8. The 2.8-kb KpnIBamHI fragment was also cloned into pMW218 by the same method and designated pKB2. 8 .
Nucleotide sequence analysis of the B. acetylicum gsk gene. The nucleotide sequence of the 2,833-bp KpnI-BamHI insert of pKB2.8 was determined in both directions. Although an open reading frame (ORF) extending from bp 522 to 1454 was detected, the gsk ORF from bp 543 to 1454 was identified on the basis of the N-terminal amino acid sequence. The complete nucleotide sequence (bp 1 to 2833) and predicted amino acid sequence are shown in Fig. 1 . The gsk ORF encodes a 303-aa polypeptide with a molecular mass of 32,536 Da, which is in good agreement with the relative molecular weight of the purified enzyme (36,300) measured by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (34) . A putative ribosomebinding sequence (dGAGGT) is located 9 bp upstream of the translational start codon for gsk.
Codon usage in the B. acetylicum gsk gene is not highly biased. The codon preference (favored codons: CAA for Gln, AAU for Asn, GAU for Asp, and UGU for Cys) is different from those of the genes of other gram-positive bacteria, Brevibacterium lactofermentum (18) and Bacillus subtilis (29) .
Expression in E. coli. To ensure that the gene encoding guanosine kinase had been isolated, specific guanosine and inosine kinase activities were measured in cell extracts from E. coli cells harboring the plasmids pKE1.8 and pKB2.8, which contained the cloned 1.8-kb KpnI-EcoRI fragment and the 2.8-kb KpnI-BamHI fragment, respectively ( Table 1 ). The basal guanosine and inosine phosphorylating activities, which might be due to the E. coli Gsk protein, were detected in the strains containing vectors (pSTV28 and pMW218). The specific guanosine and inosine kinase activities were shown to have increased by approximately 200-and 100-fold, respectively, after the introduction of the B. acetylicum gsk gene. The introduction of the gsk gene severely reduced the growth rate of the recombinant E. coli strains, whereas the overexpression of the E. coli gsk gene did not. We assume that this variation might be due to different mechanisms of regulation of the two enzymes (34) .
Protein sequence comparisons. The protein sequence data banks (PIR release 50.0 and SwissProt release 34.0) were searched for homologous proteins. This search revealed that the B. acetylicum Gsk protein shares significant sequence similarity with several sugar kinases, including ribokinases, eukaryotic ketohexokinases, and 2-dehydro-3-deoxygluconokinases. The proteins which have the highest similarity to Gsk are the E. coli hypothetical proteins YeiC and YeiI (22) . Gsk shows 25.7% identity (276 aa) with YeiC and 24.7% identity with YeiI (275 aa). A comparison of the B. acetylicum Gsk amino acid sequence with the amino acid sequence of E. coli ribokinase (11) revealed that both proteins show 21.7% identity within 249 aa, which cover a large part of the sequences (Fig.  2) . It was confirmed that the purified guanosine kinase does not have ribose phosphorylating activity by using D-[
14 C]ribose as a substrate. The B. acetylicum Gsk protein shows only low or partial homology with E. coli Gsk and other nucleoside kinases which catalyze the same nucleoside phosphorylation. Furthermore, we did not find in the B. acetylicum Gsk sequence any indication of an ATP-binding motif, which is present in other nucleoside kinases (17, 37) and other ATP-utilizing enzymes (28) .
A search by the BLAST procedure also revealed that the B. acetylicum Gsk protein shows strong similarity to sugar kinases, including ribokinases, bacterial fructokinases, ketohexokinases, 1-phosphofructokinases, and 2-dehydro-3-deoxygluconokinases, which are classified in the ribokinase family (6) . Two boxes out of three conserved boxes reported in this family (6) were well conserved in the B. acetylicum Gsk protein (Fig. 2) . Although B. acetylicum Gsk seems to be the most FIG. 1. Nucleotide sequence of the 2,833-bp KpnI-BamHI fragment containing the B. acetylicum gsk and orf2 genes. The predicted amino acid sequences of the gsk and orf2 genes are shown below the nucleotide sequence. Relevant features of the sequence are underlined and include restriction endonuclease recognition sites, promoter sequences (Ϫ35 and Ϫ10), and putative ribosome-binding sites (RBS). A transcription start site and a potential transcriptional terminator are marked by an asterisk and facing arrows, respectively. The N-terminal amino acid sequence of purified guanosine kinase is underlined. typical nucleoside kinase which belongs to this family, E. coli Gsk (6) and human adenosine kinase (32) were reported to share the conserved motif of the ribokinase family. This leads us to assume that sugar kinases which belong to the ribokinase family and nucleoside kinases with substrate specificities toward nucleosides higher than those toward 2Ј-deoxynucleoside may originate from a common ancestor gene.
Transcriptional analysis of the gsk gene and identification of the second ORF.
Northern hybridization was performed to analyze the gsk transcript. Total RNA was isolated from B. acetylicum, size fractionated, transferred to a nylon membrane, and hybridized to a labeled 0.7-kb SalI fragment. A hybridizing signal was observed at 1.4 kb (Fig. 3A) . This is much longer than the structural gsk gene, indicating that the organization of B. acetylicum gsk is polycistronic. A primer extension analysis was performed to determine the transcription initiation point (Fig. 3B) . The result showed that transcription initiation of the gsk gene occurs at adenylate residue 481. The hexanucleotide sequences TTGTCA at Ϫ35 and TATAAT at Ϫ10 were found. These sequences are in excellent agreement with the consensus sequences (TTGACA at Ϫ35 and TATAAT at Ϫ10) recognized by E. coli 70 (23) and B. subtilis A (20) . This may explain the high level of expression of the B. acetylicum gsk gene in E. coli. The nucleotide sequence downstream from the gsk gene, at positions 1483 to 1911 (Fig. 1) , was identified as the second ORF and was tentatively designated orf2. The size of the transcript corresponds closely to the sum of the sizes of the structural gsk and orf2 genes. We also found a factorindependent terminator-like sequence (23) downstream of orf2 at positions 1954 to 1979 (Fig. 1) . Although orf2 shows significant similarity to the mutT genes of E. coli (1) and Proteus vulgaris (16) , which are called mutators and have 8-oxo-7,8-dihydro-2Ј-dGTP hydrolyzing activity, its function has not yet been identified.
Growth phase-dependent expression of gsk. In cell extracts of B. acetylicum ATCC 953, strong guanosine phosphorylase activity was also detected in the presence of phosphate buffer. To clarify the role of guanosine kinase, guanosine phosphorylase, which shares the same substrate, was also examined. Specific guanosine kinase activity as a function of growth showed a remarkable contrast with specific guanosine phosphorylase activity (Fig. 4A) . The guanosine kinase activity increased in the early exponential phase (Fig. 4B) , whereas guanosine phosphorylase activity decreased in this phase (Fig. 4C) . Furthermore, relatively constitutive hypoxanthine-guanine phosphoribosyltransferase activity was detected in cell extracts, suggesting that two purine salvage pathways, i.e., formation of GMP from guanosine and from guanine, exist in this organism. Although the specific guanosine phosphorylase activity is much higher than the specific guanosine kinase activity, the K m of purine nucleoside phosphorylase of B. acetylicum ATCC 954 for guanosine has been reported to be 2.4 mM (30), which is much higher than that (0.022 mM) of the guanosine kinase (34) . Thus, the two activities which share guanosine as a substrate may be comparable under in vivo conditions and may be utilized differently depending on the growth phase. We examined the level of gsk gene expression. Total RNA extracted from early-, middle-, and late-exponentialphase cells were analyzed by primer extension (Fig. 4D) . The gsk gene was actively transcribed in the early exponential phase. This result seems to agree with the specific guanosine kinase activity profile. By contrast, no transcription was observed in the late logarithmic phase, which does not seem to correspond with the observed constant activity from the late exponential phase to the stationary phase. This might be due to the enzymes that were synthesized in the early exponential phase but remained active until the stationary phase; however, the guanosine kinase activity measured by using a crude extract solution might have included background activity due to other enzymes. Considering these results together with the facts obtained by enzymatic analyses, we think that the guanosine kinase in this organism might play a role in controlling the nucleoside monophosphate level by efficiently recycling guanosine when cells are in the early exponential phase. It may be that nucleoside is directly utilized when cells are in the growth phase, because nucleoside can be converted to nucleoside monophosphate with 1 mol of ATP; however, the conversion of nucleoside to nucleoside monophosphate via a nucleobase requires 2 mol of ATP, 1 mol for formation of 5-phosphoribosyl-1-pyrophosphate from ribose-5-phosphate and 1 mol for formation of ADP from AMP produced by the pyrophosphokinase. When cells are in the stationary phase, it seems to be preferable that excess nucleotides and nucleosides are converted to nucleobases and riboses, which can be used as energy sources.
